There is increasing evidence that activation of the classical renin-angiotensin system pathway through Angiotensin II-angiotensin-1-receptor (AT1R) drives tumor progression through enhanced tumor proliferation, migration, invasion and angiogenesis, as well as inhibition of apoptosis. This evidence concerns the gene REN and neoplasm.